Baird, L., & Yamamoto, M. (2021). NRF2-Dependent Bioactivation of Mitomycin C as a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer. Mol Cell Biol.
Chicago Style citaatBaird, Liam, en Masayuki Yamamoto. "NRF2-Dependent Bioactivation of Mitomycin C As a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer." Mol Cell Biol 2021.
MLA citatieBaird, Liam, en Masayuki Yamamoto. "NRF2-Dependent Bioactivation of Mitomycin C As a Novel Strategy To Target KEAP1-NRF2 Pathway Activation in Human Cancer." Mol Cell Biol 2021.
Let op: Deze citaties zijn niet altijd 100% accuraat.